| Name | Methyl 2-(benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-carboxylate |
|---|---|
| Synonyms |
EHMT2,G9a,BRD-4770,Histone Methyltransferase,H3K9,cell-permeable,ATR,chromatin,anti-proliferation,methylation,BRD4770,Inhibitor,BRD 4770,ATM,senescent,inhibit
BRD4770, 10 mM in DMSO BRD4770 BRD4770 //BP 2-(Benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-cboxylic acid methyl ester BRD-4770; BRD Methyl 2-benzamido-1-(3-phenylpropyl)benzimidazole-5-cboxylate methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-cboxylate BRD4770 1H-Benzimidazole-5-carboxylic acid, 2-(benzoylamino)-1-(3-phenylpropyl)-, methyl ester methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-cboxylate Methyl-2-(benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-cboxylate 1H-Benzimidazole-5-cboxylic acid, 2-(benzoylamino)-1-(3-phenylpropyl)-, methyl ester |
| Description | BRD4770 is a novel G9a(EHMT2) inhibitor with EC50 of 5 uM (trimethylated H3K9 in PANC-1 cell).IC50 value: 5 uM (PANC-1 cell) [1]Target: G9a inhibitorBRD4770 activates the ATM pathway without inducing DNA damage, while the ATR pathway is not affected. BRD4770 is a novel probe for studying G9a and its role in cellular senescence.Treatment of 5 μM BRD4770 for 24 h decreased H3K9 trimethylation level by 23% in PANC-1 cells. BRD9539 also inhibits PRC2 activity. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C25H23N3O3 |
| Molecular Weight | 413.468 |
| Exact Mass | 413.173950 |
| LogP | 5.49 |
| Appearance | white to beige |
| Index of Refraction | 1.625 |
| Storage condition | 2-8°C |
| Water Solubility | DMSO: soluble5mg/mL, clear (warmed) |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| RIDADR | NONH for all modes of transport |